| Cat. No. |
Product Name |
Information |
| PC-23132 |
Dual FXR-LIFR modulator 3a
LIFR antagonist/FXR agonist
|
Dual FXR-LIFR modulator 3a is a first-in-class hybrid leukemia inhibitory factor receptor (LIFR) inhibitor and Farnesoid X receptor (FXR) agonist with IC50 of 2.0 uM and EC50 of 3.2 uM respectively, protects against the development of acute liver fibrosis and inflammation. |
| PC-22657 |
Agmatine sulfate
FXR agonist
|
Agmatine sulfate is a microbial metabolite derived from arginine by arginine decarboxylase, activates the farnesoid X receptor (FXR) pathway to subsequently inhibit glucagon-like peptide-1 (GLP-1) secretion by L cells. |
| PC-22169 |
F44-A13
FXR antagonist
|
F44-A13 is a highly selective farnesoid X receptor (FXR) antagonist with IC50 of 1.1 uM, with high selectivity over eleven other nuclear receptors. |
| PC-20980 |
HPG1860
FXR agonist
|
HPG1860 is a potent, selective, nonbile acid full FXR agonist with EC50 of 5 nM and 18 nM in FR-FRET and luciferase assays, respectively. |
| PC-20979 |
MET409
FXR agonist
|
MET409 (MET-409) is a potent, selective farnesoid X receptor (FXR) agonist with EC50 of 16 nM (human FXR). |